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T cell functional differentiation is mediated by line-
age-specific transcription factors. T helper 17 (Th17)
has been recently identified as a distinct Th lineage
mediating tissue inflammation. Retinoic acid recep-
tor-related orphan receptor g (RORg) was shown to
regulate Th17 differentiation; RORg deficiency, how-
ever, did not completely abolish Th17 cytokine ex-
pression.Here,we report Th17 cells highly expressed
another related nuclear receptor, RORa, induced by
transforming growth factor-b and interleukin-6 (IL-
6), which is dependent on signal transducer and acti-
vator of transcription 3. Overexpression of RORa
promoted Th17 differentiation, possibly through the
conserved noncoding sequence 2 in Il17-Il17f locus.
RORa deficiency resulted in reduced IL-17 expres-
sion invitroand in vivo. Furthermore,RORaandRORg
coexpression synergistically led to greater Th17 dif-
ferentiation. Double deficiencies in RORa and RORg
globally impaired Th17 generation and completely
protected mice against experimental autoimmune
encephalomyelitis. Therefore, Th17 differentiation is
directed by two lineage-specific nuclear receptors,
RORa and RORg.
INTRODUCTION
Upon activation by antigen-presenting cells (APCs), naive
T helper (Th) cells undergo clonal expansion and functional
differentiation into cytokine-secreting effector cells. Effector Th
cells have been historically classified into Th1 and Th2 subsets
(Dong and Flavell, 2000; Glimcher and Murphy, 2000). Th1 cells
make interferon-g (IFN-g) and regulate antigen presentation and
cellular immunity. Th2 cells, on the other hand, secrete interleu-
kin-4 (IL-4), IL-5, and IL-13, which together regulate humoral and
antiparasite immunity. The cytokine environment during Th acti-
vation determines Th effector differentiation, through selective
signal transducer and activator of transcription (STAT) proteins,
leading to expression of lineage-specific master transcriptionfactors (Dong, 2006; Glimcher and Murphy, 2000). Th1 differen-
tiation and IFN-g production is promoted by IL-12, a heterodi-
meric cytokine produced by activated APCs that signals through
STAT4. The IFN-g-STAT1 pathway in turn sustains Th1 develop-
ment, leading to the induction of the transcription factor T-bet.
Additionally, IL-4, secreted by activated T cells, drives Th2 polar-
ization in a STAT6-dependent manner, resulting in activation of
the transcription factor GATA3.
A third Th subset, termed ThIL-17, Th17 or inflammatory Th
(Thi), has been recently identified as a distinct Th lineage (Bettelli
et al., 2007; Dong, 2006; Reiner, 2007; Weaver et al., 2006). Th17
differentiation is initiated by transforming growth factor-b (TGF-b)
and IL-6 in mouse (Bettelli et al., 2006; Mangan et al., 2006;
Veldhoen et al., 2006), possibly via regulation of the chromatin
remodeling of the Il17-Il17f locus (Akimzhanov et al., 2007),
which is further reinforced by IL-23 (Yang et al., 2007; Zhou
et al., 2007). Th17 cells produce IL-17, IL-17F, and IL-22, all of
which regulate inflammatory responses by tissue cells (Chung
et al., 2006; Langrish et al., 2005; Liang et al., 2006; Zheng
et al., 2007). Recently, IL-21 was reported as an autocrine factor
induced by IL-6 to regulate Th17 differentiation (Korn et al., 2007;
Nurieva et al., 2007; Zhou et al., 2007). Th17 differentiation is
negatively regulated by IFN-g, IL-4, IL-27, and IL-2 (Batten et al.,
2006; Harrington et al., 2005; Laurence et al., 2007; Park et al.,
2005; Stumhofer et al., 2006).
Analogous to STAT4 and STAT1 in Th1 and STAT6 in Th2
differentiation, STAT3 was found to selectively mediate Th17
differentiation (Laurence et al., 2007; Yang et al., 2007). Overex-
pression of a hyperactive STAT3 enhanced Th17 differentiation,
whereas STAT3 deficiency impairs Th17 differentiation in vitro
(Laurence et al., 2007; Yang et al., 2007) and in vivo (Zhou
et al., 2007). STAT3 is necessary for IL-6 induction of IL-21
expression and is required for IL-21-mediated Th17 differentia-
tion (Nurieva et al., 2007). The precise biochemical function of
STAT3 is unclear at this point. Although STAT3 has been shown
to bind to the Il17 gene promoter (Chen et al., 2006), STAT3
appears to control more than just IL-17 gene expression (Yang
et al., 2007). It is likely that, STAT3, similar to STAT1 and
STAT6, functions in regulation of lineage-specific master-tran-
scription-factor expression.
One such Th17-specific transcription factor is an orphan
nuclear receptor, RORg. The specific isoform RORgt was re-
cently shown as the first transcription factor to be selectivelyImmunity 28, 29–39, January 2008 ª2008 Elsevier Inc. 29
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RORa and RORg Regulate Th17 Differentiationexpressed in Th17 cells (Ivanov et al., 2006), and it is regulated by
STAT3 (Laurence et al., 2007; Yang et al., 2007). Overexpression
of RORgt promotes Th17 differentiation when Th1 and Th2 de-
velopment is inhibited (Ivanov et al., 2006). Conversely, RORgt
deficiency results in profound Th17 deficiency and was reported
to protect mice from experimental autoimmune encephalomyeli-
tis (EAE). However, the RORgt defect does not completely
abolish Th17 differentiation or totally inhibit EAE, suggesting
additional factors might be involved.
In the current study, we report that Th17 cells also highly
expressed another orphan nuclear receptor, RORa, which was
induced by TGF-b and IL-6 in a STAT3-dependent manner.
Overexpression of RORa promoted Th17 differentiation and
substaintially upregulates IL-17 and IL-17F expression. RORa
deficiency resulted in reduced IL-17 expression in vitro and
in vivo. Furthermore, we found that RORa and RORgt coexpres-
sion synergistically drove greater Th17 differentiation, especially
under nonfavorable conditions. Double deficiencies in RORa
and RORg entirely impaired Th17 generation in vitro and com-
pletely inhibited EAE disease. Therefore, RORa is another Th17-
specific factor that, together with RORg, directs Th17 lineage
differentiation.
RESULTS
RORa Is Highly Expressed in Th17
In a gene expression profiling analysis of in vitro-differentiated
Th1, Th2, and Th17 cells, we found that the expression of two
retinoic acid receptor (RAR)-related orphan receptor (ROR)
genes, Rora (encoding RORa) and Rorc (encoding RORg), was
elevated in Th17 cells compared to Th1 or Th2 cells (data not
shown). The ROR family comprises three members, RORa,
RORb, and RORg (Jetten, 2004). Although RORb is not
expressed in Th17 cells (data not shown), RORg, in particular
the RORgt isoform, was previously identified as a critical tran-
scription factor regulating Th17 differentiation (Ivanov et al.,
2006). Whether RORa, specifically the isoform 4 that is
expressed in Th17 cells (data not shown), is also involved in
Th17 regulation has not yet been established. To examine the
potential role of RORa, we first assessed the expression of
RORa in Th1, Th2, and Th17 subsets. CD4+ T cells purified
from OT-II mice were differentiated under neutral condition or
into Th1, Th2, and Th17 cells, and the expression of Rora and
Rorc (encoding RORgt) messenger RNA (mRNA) was measured
on day 5 by quantitative real-time reverse transcriptase-poly-
merase chain reaction (RT-PCR). As demonstrated for Rorc,
Rora mRNA was found to be highly expressed in Th17, com-
pared with Th1 and Th2 (Figure 1A).
Th17 differentiation is initiated by TGF-b and IL-6 (Bettelli et al.,
2006; Mangan et al., 2006; Veldhoen et al., 2006) and reinforced
by IL-23 (Yang et al., 2007). We next asked whether these cyto-
kines regulate RORa expression. CD4+CD25CD62LhiCD44lo
naive T cells purified by fluorescence-activated cell sorting
(FACS) were activated with plate-bound anti-CD3 and anti-
CD28 in the presence of various cytokines for 1, 2, and 5 days.
On days 1 and 2, IL-23 alone had no effect on Rora mRNA
expression; the combination of TGF-b and IL-6 synergistically
upregulated Rora mRNA expression (Figure 1B), correlating30 Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc.with the induction of Il17 and Il17f gene transcription (Akimzha-
nov et al., 2007). On day 5, either IL-6 or TGF-b increased Rora
mRNA, and the combination of TGF-b and IL-6 further enhanced
Rora mRNA expression (Figure 1B).
We and others previously showed that STAT3 is an essential
factor regulating cytokine-mediated Th17 differentiation and
that Rorc is regulated by STAT3 (Laurence et al., 2007; Yang
et al., 2007). To determine whether Rora expression is STAT3-
dependent, we purified naive T cells from Stat3f/D Tie2-Cre+
(Stat3/) or wild-type (WT) mice and differentiated them into
Th17 cells by using the following two conditions: (1) TGF-b,
IL-6, TNF-a plus IL-1b and (2) TGF-b, IL-6, IL-23, and blocking
antibodies against IL-4 and IFN-g. Real-time RT-PCR revealed
that under both conditions, Rora mRNA expression was defec-
tive in STAT3-deficient cells in comparison with control cells
(Figure 1C). Therefore, like Rorc, Rora is highly expressed in
Th17 cells in a STAT3-dependent manner.
RORa Overexpression Drives Th17 Differentiation
In order to assess RORa function in Th17 differentiation, we
overexpressed RORa by retroviral transduction. Naive CD4+ T
cells from OT-II mice were FACS purified and activated with
Ova peptide and splenic APCs in the presence of blocking anti-
bodies to IL-4 and IFN-g. On day 2, the activated cells were
infected with bicistronic retroviruses containing an IRES-GFP.
Three days after infection, IL-17- and IFN-g-expressing cells
were measured by intracellular staining. Compared to infection
with a control virus, transduction of RORa-encoding virus sub-
stantially increased the percentage of IL-17-secreting cells
even in the absence of TGF-b and IL-6 and reduced the
frequency of IFN-g-producing cells (Figure 2A). Anti-IL-17 stain-
ing correlated with high amount of green fluorescent protein
(GFP) expression, and GFP-negative cells did not exhibit any in-
crease in IL-17 expression (Figure S1 available online), indicating
a cell-intrinsic effect by RORa. In the presence of TGF-b or IL-6,
RORa facilitated Th17 differentiation and further enhanced this
process in the presence of both factors (Figure 2A). To further
understand the role of RORa in directing the Th17 program, we
sorted GFP+ cells from the retrovirus-transduced cells differenti-
ated under neutral conditions and assessed their gene expres-
sion profiles with real-time RT-PCR. RORa overexpression
greatly enhanced Il17, Il17f, and Il23rmRNAexpression,whereas
Il22 expression was moderately increased (Figure 2B). Further-
more, RORa overexpression facilitated Th17 differentiation in
RORg-deficient cells (Figure S1). Thus, RORa promotes Th17
differentiation and is sufficient to upregulate most of Th17-
specific genes.
How RORgt regulates Th17 differentiation is poorly under-
stood. Because RORa and RORg are highly homologous in their
DNA-binding motif, we search for putative ROR response ele-
ments (ROREs) in the Il17-Il17f locus. Although Il17 and Il17f
gene promoters do not have perfect ROREs, we noticed that
the CNS2 site contains two ROREs that are also conserved in
human. We previously found CNS2 to be evolutionarily con-
served and associated with acetylated histone H3 in Th17 but
not Th1 or Th2 cells (Akimzhanov et al., 2007). Furthermore, we
found that this chromatin change at CNS2 was initiated by
both TGF-b and IL-6 (Figure 2C). To further characterize the
potential regulation of CNS2 by ROR factors, we performed
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RORa and RORg Regulate Th17 DifferentiationFigure 1. RORa Is Highly Expressed in Th17 Cells
(A) CD4+ T cells from OT-II mice were differentiated with Ova323–339 peptide and splenic APCs under neutral (Th0), Th1, Th2, and Th17 conditions for 5 days, and
Rora andRorc (encoding RORgt) mRNA expression was assessed by real-time RT-PCR after restimulation of T cells by anti-CD3 for 4 hr. Data shown are derived
from two independent experiments with consistent results and normalized with expression amounts of Actb. Expression in Th0 was set to 1.
(B) FACS-sorted naive CD4+CD25CD62LhiCD44lo T cells from C57BL/6 mice were activated with anti-CD3 and anti-CD28 in the presence of indicated cytokine
stimuli for 1, 2, or 5 days, and Rora and Rorc mRNA expression was assessed by real-time RT-PCR. Expression in the condition without exogenous cytokine
stimulus was set to 1.
(C) Naive CD4+ T cells from Stat3/ or wild-type (WT) mice were activated with plate-bound anti-CD3 and anti-CD28 under the indicated stimuli for 4–5 days.
RoramRNA expression was assessed by real-time RT-PCR. The expression amount in Stat3/ cells was set to 1. The experiments were repeated at least three
times with consistent results. A p value% 0.05 by an unpaired Student’s t test is marked by asterisks.electrophoresis mobility shift assay (EMSA) with a CNS2 oligo-
nucleotide probe containing a RORE. Nuclear factors from
Th17 cells were found to bind to this CNS2 probe (Figure 2D)
but not to a CNS2 probe containing a mutation in the RORE
(data not shown). Furthermore, the unlabelled consensus probe
but not the mutant CNS2 probe diminished this binding in
a dose-dependent manner (Figure 2D). ROR factor binding to
CNS2 was detected by chromatin immunoprecipitation assay
in Th cells overexpressing RORa or RORgt (Figure S2). To deter-
mine whether RORa and RORgt regulate the activity of CNS2,
we cloned this element together with a minimal promoter of
the Il17 gene in front of a luciferase reporter. In EL-4 cells, the
minimal Il17 promoter alone was not activated by RORa and/or
RORgt (Figure 2E). In the presence of CNS2, either RORa or
RORgt enhanced the transcription of IL-17 promoter (Figure 2E).
There was no synergistic effect when both were coexpressed
(Figure 2E). Thus, overexpression of RORa facilitated Th17 dif-
ferentiation, possibly through chromatin remodeling of CNS2 in
the Il17-Il17f locus.
RORa Deficiency Reduced IL-17 Expression
Therefore, RORa, like RORgt, is sufficient in inducing the Th17
program. We next tested the function of RORa by using Stag-
gerer mice, which bear a spontaneous deletion in RORa ligand-
binding domain and exhibit the same phenotype as the RORa-
deficient mice (Hamilton et al., 1996; Steinmayr et al., 1998).
When naive CD4+ T cells isolated from homozygous Staggerer(referred to asRorasg/sg hereafter) orWT splenocytes were differ-
entiated into Th17 cells, reduction in IL-17-producing cells was
observed inRorasg/sg versusWT cells under the stimuli of TGF-b,
IL-6, TNF-a, and IL-1b, but this reduction was less pronounced
when cells were differentiated in the presence of TGF-b, IL-6,
IL-23, anti-IL-4, and anti-IFN-g (Figure 3A). When analyzed by
real-time RT-PCR, in addition to reduced Il17mRNA expression,
Il23r mRNA was also consistently decreased in Rorasg/sg cells
(Figure 3B). In contrast, Tbx21 (encoding T-bet) mRNA was in-
creased in Rorasg/sg samples, suggesting that RORa not only
promotes the Th17 program but also might inhibit the Th1 pro-
gram. Unlike Il17 and Il23r, the expression of Il22, Il21, and Il17f
mRNAwas not affected by RORa deficiency (Figure 3B), indicat-
ing differential dependency of Th17 cytokines on RORa.
To understand the function of RORa in vivo, we employed
experimental autoimmune encephalomyelitis (EAE), a Th17-me-
diated central nerve system (CNS)-inflammation disease model
(Langrish et al., 2005; Park et al., 2005). Because Rorasg/sg
mice have developmental defects in brain (Hamilton et al.,
1996), we reconstituted Rag1/ mice on C57BL/6 background
with bone marrow cells from Rorasg/sg or WT mice. Rorasg/sg
hematopoietic stem cells were previously shown to reconstitute
lymphoid compartments in Rag-deficient mice (Dzhagalov et al.,
2004). EAE was induced in the chimeric mice with MOG peptide.
In comparison with mice reconstituted with WT bone marrow
cells, Rorasg/sg-constituted mice exhibited the same disease in-
cidence, but fewer mice in this group developed limb paralysisImmunity 28, 29–39, January 2008 ª2008 Elsevier Inc. 31
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RORa and RORg Regulate Th17 DifferentiationFigure 2. RORa Overexpression Promotes Th17 Differentiation
(A) FACS-sorted naive OT-II CD4+ T cells were activated with splenic APCs pulsed with Ova peptide in the presence of blocking antibodies for IL-4 and IFN-g and
the indicated stimuli and infectedwith an IRES-GFP-containing bicistronic retrovirus expressing RORa or a vector control virus. IL-17- and IFN-g-expressing cells
were measured by intracellular staining on a GFP+ gate. The experiments were repeated at least for three times with consistent results.
(B) GFP+ cells were sorted from the above neutral culture conditions, and mRNA expression was measured by real-time RT-PCR. Expression in cells transduced
with the vector control virus was set to 1.
(C) Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 in the presence of indicated stimuli for 2 days, and histone H3 acetylation in CNS2 of Il17-Il17f
locus was assessed by chromatin immunoprecipitation (ChIP) and PCR with two different pairs of primers (2a and 2b). Data were normalized to levels of histone
H3 acetylation at the Actb promoter.
(D) ROR binding to the RORE at CNS2 was assessed by electrophoretic mobility shift assay. Nuclear proteins were prepared from Th17 cells differentiated from
naive OT-II T cells with splenic APCs pulsed with Ova peptide in the presence of polarizing cytokines. A CNS2 RORE was used as probe. Competitors were a
consensus element and a mutant of the CNS2 RORE.
(E) RORa or RORg overexpression enhances transcription from an Il17minimal promoter in the presence of CNS2. EL-4 cells were transfectedwith RORa, RORg,
both, or vector alone with an Il17 promoter (promoter) or Il17 promoter-CNS2 (promoter+CNS2) luciferase reporter vector. Renilla luciferase was used for the
normalization of transfection efficiency. Background luciferase activities in cells transfected with promoter reporter, and empty vectors were set to 1. Data shown
represent two independent experiments with similar results.(scoreR 3) (Figure 4A). To further understand the impact of the
RORamutation on EAE pathogenesis, we sacrificed both groups
of mice on day 14 after the second immunization and examined
IL-17- and IFN-g-expressing cells in the CNS and spleen by
intracellular staining. The CNS infiltrates in Rorasg/sg chimeras
contained fewer numbers of IL-17-secreting cells than did those
in WT chimeras (Figure 4B). The number of IL-17-producing
CD4+ T cells in spleen was decreased upon restimulation,
32 Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc.whereas the number of IFN-g-expressing cells was increased
in Rag1/ mice reconstituted with Rorasg/sg cells versus those
with WT cells (Figure 4B). Moreover, after restimulation with
MOG peptide, Rorasg/sg splenocytes exhibited reduced IL-17
and increased IFN-g expression compared to WT cells, whereas
IL-22 production was not affected (Figure 4C). Thus, our in vitro
and in vivo analysis indicated that IL-17 expression is selectively
dependent on RORa.
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RORa and RORg Regulate Th17 DifferentiationFigure 3. RORa Deficiency Reduces IL-17 Production In Vitro
(A) FACS-sorted naive CD4+ T cells from WT or Rorasg/sg mice were activated under the indicated conditions for 4 days. IL-17- or IFN-g-expressing cells were
measured by intracellular staining. The experiments were repeated at least three times.
(B) Total RNAwas isolated from the above culture, andmRNA expression for indicated genes was assessed by real-time RT-PCR. The lowest expression in each
PCR was set to 1. A p value% 0.05 by an unpaired Student’s t test is marked by asterisks.RORa and RORgt Coexpression Synergistically
Promotes Th17 Differentiation In Vitro
RORa exhibits a similar expression pattern as RORgt, and both
factors appear to regulate Th17 differentiation. To understand
why both receptors are coexpressed in Th17 cells, we first exam-
ined whether RORa synergizes with RORgt in programming the
Th17 lineage by using a retroviral coinfection strategy. Naive
OT-II T cells were activated as above and coinfected with two
viruses expressing RORa-GFP or GFP vector and RORgt-
hCD2 or hCD2 vector. IL-17- and IFN-g-secreting cells were
assessed by intracellular staining on a GFP+hCD2+ gate. Under
neutral conditions, either RORa or RORgt but not the control vi-
rus was sufficient to promote the generation of IL-17-producing
cells (Figure 5). Remarkably, in the absence of exogenous cyto-
kine, coexpression of RORa and RORgt led to greatly enhanced
IL-17 production. No effect was observed on GFP-negative
nontransduced cells (Figure S3A), indicating a cell-intrinsic reg-
ulation. RORa was found to enhance the numbers of IL-17-
expressing T cells in a dose-dependent manner in cells express-
ing no, low, or high amounts of RORgt-hCD2 (Figure S3A). To
further understand the relationship between RORa and RORgt
in directing Th17 differentiation, we sorted out the GFP+hCD2+
cells from the culture above and examined the expression of
Th17-specific genes by RT-PCR. Compared with cells infected
with control viruses, RORa or RORgt alone increased Il17,
Il17f, and Il23r mRNA expression, whereas coexpression of
RORa and RORgt synergistically upregulated Il17, Il17f, Il23r,
and Il22 mRNA (Figure S3B). RORa or RORgt expression also
downregulated Tbx21 mRNA expression (Figure S3C). Associ-
ated with activation of Th17-specific genes, we found that
histone H3 acetylation was enhanced by RORa and RORgt atthe CNS2 but not the Il17 gene promoter (Figure S3D), further
supporting CNS2 as a potential direct target of ROR factors.
We next tested whether combined expression of RORa and
RORgt could induce Th17 cells under conditions that favor differ-
entiation of other subsets. Naive OT-II T cells were activated with
TGF-b to induce regulatory T cells (iTreg) or under Th1 and Th2
polarized conditions and infected with RORa, RORgt and/or
empty vector viruses. IL-17- and Foxp3- (for iTreg), IFN-g- (for
Th1), or IL-5- (for Th2) expressing cells were assessed by intra-
cellular staining in a GFP+hCD2+ gate. Under iTreg-inducing
conditions, RORa appears to downregulate Foxp3 expression;
RORa and RORgt synergistically induced IL-17 expression (Fig-
ure 5). Under the Th1-inducing conditions, neither RORa nor
RORgt overexpression alone resulted in substantial numbers
of Th17 cells, whereas coexpression of RORa and RORgt
promoted Th17 differentiation and partially inhibited Th1 devel-
opment (Figure 5). Under the Th2-inducing conditions, interest-
ingly, either of the two receptors led to Th17 differentiation.
Furthermore their coexpression greatly increased Th17 cell num-
bers and Th17-specific gene expression (Figure 5, Figure S3E).
Thus, RORa and RORgt together promote Th17 development
and are required to antagonize the Th1 program.
RORa and RORg Double Deficiencies Completely
Impaired Th17 Differentiation
Because RORa or RORgt single deficiency did not completely
abrogate Th17 differentiation, we analyzed RORa and RORg
double-deficient (Rorasg/sgRorc/) cells in Th17 differentiation.
Naive T cells were isolated from Rorasg/sgRorc/, Rorc/,
and WT mice and differentiated under Th17 conditions in the
presence of IL-6 or IL-21 with or without anti-IL-2. In comparison
Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc. 33
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RORa and RORg Regulate Th17 Differentiationto WT T cells, IL-17-secreting cell numbers were greatly reduced
in Rorc/ cells and completely impaired in Rorasg/sgRorc/
double-deficient cells (Figure 6A, Figures S4 and S5). With
real-time RT-PCR, RORg deficiency resulted in reduction
of Il17, Il17f, Il22, and Il23r mRNA expression compared to
WT, whereas Rorasg/sgRorc/ double deficiencies completely
Figure 4. RORa Deficiency Reduces IL-17
Production In Vivo
(A) Rag1/ mice were reconstituted with bone
marrow from Rorasg/sg (n = 9) or WT (n = 10)
mice. Six to eight weeks later, EAE was induced
in the chimeric mice. Data shown are a combina-
tion of two independent experiments.Max disease
was set as score R 3. A p value < 0.05 by an
unpaired Student’s t test is marked by asterisks.
(B) Infiltrates in central nerve system or spleno-
cytes from the EAE mice were isolated on day 14
after the second immunization and restimulated
with PMA-Ionomycin and MOG35–55 peptide, re-
spectively. IL-17- or IFN-g-expressing cells were
measured by intracellular staining. Data shown
are on gated CD4+ T cells. The following abbrevi-
ations are used: central nerve system (CNS) and
spleen (Sp).
(C) Splenocytes from the above mice were stimu-
lated with MOG peptide, and cytokine expression
was measured by enzyme-linked immunosorbent
assay (ELISA). Mean values are shown as horizon-
tal bars. Data shown represent two independent
experiments with consistent results.
Figure 5. RORa and RORgt Synergizes
in Promoting Th17 Differentiation
Naive OT-II CD4+ T cells were activated with Ova
peptide-pulsed splenic APCs under the neutral
(anti-IL-4 and anti-IFN-g), iTreg (inducible regula-
tory T cells, TGF-b, anti-IL-4, and anti-IFN-g),
Th1, or Th2 conditions and coinfected with two
bicistronic retroviruses expressing RORa-GFP or
GFP vector and RORgt-hCD2 or hCD2. Cytokine-
or Foxp3-expressing cells were assessed by intra-
cellular staining. Data shown are gated on
GFP+hCD2+ cells. The experiments were repeated
at least twice with consistent results.
34 Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc.
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ciencies Completely Abrogate Th17 Differ-
entiation In Vitro
Naive CD4+CD25CD62LhiCD44lo T cells from
spleens of Rorc/, Rorasg/sgRorc/, or WT
mice were activated with plated-bound anti-CD3
and anti-CD28 under the indicated conditions.
(A) IL-17- and IFN-g-secreting cells were as-
sessed by intracellular staining. Protein amounts
of IL-17 were measured by ELISA after anti-CD3
restimulation.
(B) Expression of indicated genes was measured
by real-time RT-PCR. The lowest expression
amounts for each gene were set to 1.
a modest reduction of IL-17-expressing
cells in Rorasg/sg chimeras compared to
Rorc/ chimeras (Figure 7A). In Rag1/
Rorasg/sgRorc/ animals, the total
number of cells recovered from lamina
propria was consistently lower than the
other groups of chimeric mice (data
not shown), and these cells were
most profoundly impaired in IL-17 ex-
pression (Figure 7A).
Next, we subjected Rag1/ chimeric
mice containingWT, Rorc/, or Rorasg/sg
Rorc/ lymphocytes to EAE. With our
EAE protocol, the onset and severity of
disease were only moderately reduced in
Rag1/micecontainingRorc/ lympho-
cytes (Figure 7B). However, in sharp con-
trast, all mice containing doubly deficient
cells were completely protected against
this disease, with no sign of neurologicalabrogated the expression of all these genes (Figure 6B). More-
over, although Il21mRNA expression was not affected in T cells
lacking RORg (Figure 6B), we found that double deficiencies
greatly reduced the expression of IL-21 mRNA (Figure 6B).
To further understand the contribution of RORa and RORg
in vivo, we reconstituted Rag1/ mice with bone marrow cells
from WT, Rorc/, or Rorasg/sgRorc/ animals. Rorc/ hema-
topoietic stem cells were previously shown to reconstitute lym-
phoid compartments in Rag-deficient mice (Ivanov et al.,
2006). Similar to singly defective cells, reconstitution with
Rorasg/sgRorc/ bone marrow cells gave rise to normal CD4+
T cell numbers in blood or spleen, whereas in peripheral and
mesenteric lymph nodes, Rorasg/sgRorc/ exhibited reduced
CD4+ T cell numbers compared to WT or Rorasg/sg chimera but
were comparable to Rorc/ chimeras (Figure S6 and data not
shown). Similar to CD4+ T cells from Rorasg/sgRorc/ animals,
those from Rag1/ mice with Rorasg/sgRorc/ lymphocytes
also exhibited profound Th17 defects during in vitro differentia-
tion, whereas their induction of Foxp3 expression in response
to TGF-b was normal (Figure S7). CD4+ T cells in lamina propria
were previously reported to express IL-17 constitutively, which is
partially dependent on RORg (Ivanov et al., 2006). We foundimpairments (Figure 7B). When we exam-
ined infiltrating mononuclear cells in the central nervous system
and splenic CD4+ T cells, Rorc/ animals had severely reduced
but still detectable IL-17+ cells, whereasRorasg/sgRorc/ animals
had virtually none (Figure 7B). IFN-g production was not defective
in these animals (Figure 7B), suggesting that there was a selective
defect inTh17differentiation in theabsenceofRORgorbothRORa
and RORg. To further confirm the role of RORa and RORg in initial
differentiation of IL-17-producingTh17cells in vivo,we immunized
Rag1/mice constitutedwithWTand doubly deficient bonemar-
row cells with keyhole limpet hemocyanin (KLH) in complete
Freund’s adjuvant (CFA). One week later, spleen cells from immu-
nizedmicewereanalyzedfor IL-17and IFN-gexpression.Although
CD4+ T cells fromRag1/-Rorasg/sgRorc/mice exhibited IFN-g
expression, IL-17-producing cells were almost completely absent
(Figure S8). Taken together, these results indicate that compound
mutation of bothRORa andRORg resulted in impairedTh17differ-
entiation in vivo and complete protection against EAE.
DISCUSSION
T cell functional differentiation is regulated not only by cytokines
from the environment but also their intrinsic programs. Th17 as
Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc. 35
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RORa and RORg Regulate Th17 DifferentiationFigure 7. RORa and RORg Compound Mutations Completely Inhibit Th17 Differentiation In Vivo
(A) Lamina propria cells were isolated fromRag1/mice reconstituted with Rorasg/sg,Rorc/,Rorasg/sgRorc/, or WT bonemarrow cells, and IL-17 expression
was assessed by intracellular staining. p values were calculated by an unpaired Student’s t test; * indicates p < 0.05, and ** indicates p < 0.005.
(B) EAE was induced in the Rag1-deficient mice reconstituted with indicated bone marrow cells (WT, n = 5; Rorc/, n = 4; and Rorasg/sgRorc/, n = 5). Max
disease was set as score R 3. p values were calculated by an unpaired Student’s t test; * indicates Rorasg/sgRorc/ versus WT, p < 0.001, and Rorasg/sg
Rorc/ versus Rorc/, p < 0.05. Infiltrates in central nerve system or splenocytes from the EAE mice were isolated on day 13 after the second immunization,
and IL-17- or IFN-g-expressing cells were measured by intracellular staining. Data shown are on gated CD4+ T cells.a novel lineage of T cells has now been shown to be positively
and negatively regulated by many cytokines. However, the
genetic programming of their lineage differentiation in response
to these cytokines is not well understood. In the current study,
we found that RORa, downstream of STAT3, functions together
with RORg in directing Th17 differentiation and cytokine
expression.
RORa, regulated by STAT3, is selectively expressed in Th17
cells. RORa overexpression promotes IL-17 and IL-17F but not
IL-22 expression. However, RORa deficiency only selectively
impairs IL-17 but not IL-17F expression. In the absence of
RORg, RORa accounts for the remaining IL-17F production.
RORa thus appears to be more important for IL-17 expression
among the Th17 cytokines. Past work has indicated that T helper
cell cytokine expression is not only determined by master regu-
lators but also regulated by other lineage-specific transcription
factors that fine tune specific gene expression. For example, in
Th1 cells, H2.0-like homeobox (Hlx) genetically interacts with
T-bet to promote the Th1 response (Mullen et al., 2002; Zheng
et al., 2004). In Th2 cells, avian musculoaponeurotic fibrosar-
coma (v-maf), AS42 oncogene homolog (c-Maf), and Jun-B
oncogene (Junb) selectively regulate IL-4 expression (Kim
et al., 1999; Li et al., 1999). We previously found the ICOS-c-
Maf pathway controls IL-4 but not IL-5 or IL-10 expression in
36 Immunity 28, 29–39, January 2008 ª2008 Elsevier Inc.effector Th2 cells, and ICOS deficiency selectively abrogates
IL-4-dependent IgE production but not IL-5-mediated airway
eosinophilia (Dong et al., 2001; Nurieva et al., 2003). Interest-
ingly, recently we observed different ratios of IL-17 and IL-17F
expression in different T cell populations in vitro and in vivo
(X.O.Y. and C.D., unpublished data). This suggests differential
cytokine expression in differentiated Th17 cells. Whether
RORa regulates this differential regulation is unknown at this
point. Nor was the biological or pathologic significance of this
regulation. In addition to IL-17 regulation, RORa also appears
to upregulate IL-23R and downregulate IFN-g and T-bet expres-
sion. The molecular basis of this regulation also requires further
investigation.
Because RORa or RORg on their own are sufficient to induce
Th17 differentiation under neutral conditions, it is curious why
both are coexpressed in Th17 cells. Single ROR overexpression
or deficiency did not substantially alter the expression of the
other (data not shown), suggesting that these are two parallel
but not sequential or interdependent pathways induced by
STAT3. In support of this idea, RORa expression in RORg-
deficient cells drove Th17 differentiation, indicating that RORa
could function independently of RORg. Our retroviral coexpres-
sion has revealed a synergistic function by RORa and RORg
during Th differentiation. The molecular basis for this synergy
Immunity
RORa and RORg Regulate Th17 Differentiationis unclear at this point. ROR factors do not typically form het-
erodimeric complexes, which we confirmed via overexpression
and coimmunoprecipitation of RORa and RORgt (data not
shown). Moreover, we did not observe any synergy of the
two factors in activating CNS2-Il17 reporter expression. Al-
though it is possible that RORa and RORg synergistically acti-
vate some other elements in the locus, our data also strongly
suggest a dose-dependent function of RORs in activation of
IL-17 production. Low expression of RORa or RORgt did not
effectively induce IL-17 expression (Figure S1). Moreover,
RORa enhanced IL-17 production in a dose-dependent man-
ner in cells expressing variable concentrations of RORgt
(Figure S3A). These observations from retrovirus overexpres-
sion experiments suggest that when RORgt is expressed at
physiological concentrations, it requires the presence of
RORa to induce Th17 differentiation effectively. Alternatively,
both receptors are activated by similar but different ligands
that can be regulated differentially to control the amount of
proinflammatory Th17 cells. Coexpression and coactivation
of both factors is necessary to counteract the inhibitory mech-
anisms to reach the threshold amounts for Th17 differentiation.
In support of this idea, we observed that during polarized dif-
ferentiation of T cells into Th1, Th2, or iTreg cells, RORs each
had a different capacity for supporting Th17 development—
Th2 was the easiest and Th1 the most difficult program to
overcome. Consistent with these results, we found that Th17
differentiation was strongly inhibited by T-bet and Foxp3 but
not by GATA-3 (data not shown). RORa and RORg can both
be induced to some extent by TGF-b and IL-6; however, this
amount of expression might not be sufficient to drive Th17
differentiation.
In addition, our results also indicate redundancy of ROR
factors. Although RORg deficiency substantially inhibits Th17
differentiation, Th17 development was not completely abro-
gated (Ivanov et al., 2006). The addition of RORa mutation fur-
ther diminished the expression of Th17-specific genes. The
redundancy is best seen in terms of IL-21 expression.
Although single mutation did not affect IL-21 production, the
compound mutation greatly inhibited it. In our EAE model in-
volving two CFA immunizations, whereas Rorc/ cell-recon-
stituted mice only exhibited moderately reduced EAE—in con-
trast to an earlier report using RORgt-deficient mice (Ivanov
et al., 2006)—RORa and RORg double deficiencies led to
complete protection. Because IFN-g production is not dimin-
ished in the absence of both ROR factors, our current results,
in agreement with our data on Il21/ (Nurieva et al., 2007) and
Il17/ (X.O.Y., R.N., and C.D., unpublished data) mice, sup-
port Th17 cells as pathogenic mediators in this disease. Our
data also suggest that simultaneous inhibition of RORa and
RORg would be most beneficial for treatment of autoimmune
diseases, although it is not clear at this stage whether they
are required for maintaining the Th17 programs after terminal
differentiation.
In summary, our study has elucidated the function of RORa,
another Th17-lineage-specific transcription factor, and its
synergy and redundancy with RORg. This work not only demon-
strates genetic interaction between two nuclear receptors in
Th17 differentiation but also reveals the complexity in the regula-
tion of Th17 program and function.EXPERIMENTAL PROCEDURES
Mice
Heterozygous Staggerer (Rorasg/+) mice on C57BL/6 background were
obtained from Jackson Laboratory and interbred for the generation of
Rorasg/sg mice. Some Rorasg/sg mice die after birth, but a few survive to adult-
hood and were used for some experiments. Their CD4+ T cells in spleen ex-
hibited normal naive and regulatory T cell population (data not shown).
Rorc/ mice, described previously (Kurebayashi et al., 2000), were back-
crossed six to seven generations onto C57BL/6 background, and their CD4
T cells in spleen were used for some experiments in the study. Rorasg/sg
Rorc/ mice were generated by crossing of heterozygous Rorasg/+ mice
with Rorc/ mice and subsequent mating of Rorasg/+Rorc/ mice (Kang
et al., 2007). Some Rorasg/sgRorc/ mice survived to adulthood and were
used in our studies. Their splenic CD4+ T cells exhibited normal regulatory T
cell compartment (data not shown). Stat3 fl and Tie2-Cre mice were bred to
yield f/D Cre+ and Cre littermates as described (Yang et al., 2007), and their
spleen and lymph node cells were used for in vitro differentiation. Rorasg/sg,
Rorc/, Rorasg/sgRorc/, and WT bone marrow chimeras were generated
by reconstitution of 5 3 106 bone marrow cells from above mice into suble-
thally irradiated (500 rad) Rag1/ mice on the same background. The animal
experiments were performed at the age of 6–10 weeks with protocols ap-
proved by Institutional Animal Care and Use Committee.
T Cell Differentiation
Differentiation of OT-II cells in Figure 1A was performed with Ova peptide,
splenic APCs from C57BL/6 mice in the absence (for neutral differentiation)
or presence of polarizing cytokines (10 mg/ml anti-IL-4 and 2 ng/ml IL-12 for
Th1; 10 mg/ml anti-IFN-g and 10 ng/ml IL-4 for Th2; and 10 ng/ml IL-6, 5 ng/
ml TGF-b, 50 ng/ml IL-23, 10 mg/ml anti-IL-4, and 10 mg/ml anti-IFN-g for
Th17 differentiation) as previously described (Chung et al., 2006). For naive T
cell differentiation in other experiments, CD4+CD25CD62LhiCD44lo cells
were FACS sorted as described (Nurieva et al., 2007; Yang et al., 2007). Naive
CD4+ T cells were activated with plate-bound 2 mg/ml anti-CD3 and 2 mg/ml
anti-CD28 and in the presence of 50 units/ml IL-2 (in some experiments, exog-
enous IL-2 was not added or 10 mg/ml anti-IL2 was added instead of IL-2),
2.5 ng/ml TGF-b (Peprotech), 30 ng/ml IL-6 (Peprotech), 50 ng/ml IL-23
(R&D systems), 10 mg/ml anti-IL-4 (11B11), 10 mg/ml anti-IFN-g (XMG 1.2),
10 ng/ml TNF-a, 10 ng/ml IL-1b, or combination of these stimuli. Four to five
days after activation, cells were washed and restimulated with phorbol 12-
myristate 13-acetate (PMA) and ionomycin in the presence of Golgi-stop for
5 hr, after which IL-17- and IFN-g-producing cells were analyzed with intracel-
lular staining. Intracellular staining for Foxp3 was performed with a Foxp3
staining kit (eBioscience).
Quantitative Real-Time PCR
Total RNA was prepared from T cells with TriZol reagent (Invitrogen). Comple-
mentary DNA (cDNA) was synthesized with Superscript reverse transcriptase
and oligo(dT) primers (Invitrogen), and gene expression was examined with
a Bio-Rad iCycler Optical System with iQ SYBR green real-time PCR kit
(Bio-Rad Laboratories). The data were normalized to Actb reference. Rora
primers were forward, 50-TCTCCCTGCGCTCTCCGCAC-30, and reverse,
50-TCCACAGATCTTGCATGGA-30, detecting the predominant isoform 4
expressed in Th17. The primers for Il17, Il17f, Il23r, Il22, Il21, Rorc (encoding
isoform RORgt), Tbx21, and Actb were previously described (Nurieva et al.,
2007; Yang et al., 2007).
Retroviral Transduction
Genes encoding RORa (GenBank accession number XM_903197) and RORgt
(GenBank accession number AJ132394) were cloned into bicistronic retroviral
vector pGFP-RV (Ouyang et al., 1998) or pMIG-hCD2 (Deftos et al., 1998)
containing IRES-regulated GFP and human CD2, respectively. Naive
CD4+CD25CD62LhiCD44lo T cells from OT-II mice were FACS sorted and
activated with Ova323–339 peptide and irradiated wild-type splenic APCs in
the presence or absence of 2.5 ng/ml TGF-b, 30 ng/ml IL-6, 10 ng/ml IL-4
(Peprotech), 10 ng/ml IL-12 (Peprotech), 10 mg/ml anti-IL-4, 10 mg/ml anti-
IFN-g, or combination of these stimuli, as indicated. Twenty-four hours after
activation, the cells were infected by retroviruses expressing RORa-GFP or
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the cells were restimulated with PMA and ionomycin in the presence of
Golgi-stop for 5 hr, after which IL-17- and IFN-g-producing cells were analyzed
with intracellular staining on a GFP+ gate. Coinfection was performed with two
bicistronic retroviruses expressing RORa or empty vector (both have IRES-
GFP) and RORgt or control vector (both with IRES-hCD2). The analysis was
performed on a GFP+hCD2+ gate.
EAE Induction
For the induction of EAE, female bone marrow chimeric mice were immunized
with the MOG peptide emulsified in CFA. Mice were immunized subcutane-
ously at the dorsal flanks with 150 mg of MOG peptide in CFA at day 0 and
day 7. Pertussis toxin was given intraperitoneally at day 1 and day 8 with the
dosage of 500 ng per mouse. Signs of EAE were assigned scores on a scale
of 1–5 as follows: 0, none; 1, limp tail or waddling gait with tail tonicity; 2, wob-
bly gait; 3, hind-limb paralysis; 4, hind-limb and forelimb paralysis; 5, death. In
Figures 2C–2E, disease incidence and max scores from two independent
experiments were combined and p values calculated with the Student’s
t test by comparison of the disease scores. For analysis of central nervous
system infiltrates, both brain and spinal cord were collected from perfused
mice, and mononuclear cells were prepared by percoll gradient.
Transcription Reporter Assay
Expression vectors encoding RORa or RORg were transfected into EL-4 cells
with luciferase constructs containing Il17 minimal promoter (1131 to +1 rel-
ative to translation start site) with or without CNS2 element (2.3 kb; the cloning
primers were 50-TGTTTGTGGGTGTATGAG-30 and 50-GAATCCCGTTCTAAT
GTGAC-30). The dual-luciferase reporter system (Promega) was used for as-
saying of firefly and Renilla luciferase activity in each sample. Renilla luciferase
was used for the normalization of transfection efficiency and luciferase activity.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (ChIP) assays were carried out as described
(Akimzhanov et al., 2007). In brief, cells were crosslinked with formaldehyde,
and after the nuclei were isolated and sonicated, DNA-protein complexes
were immunoprecipitated with protein-A sepharose preblocked with salmon
sperm DNA with anti-acetylated histone H3 Ab (# 06-599, Upstate [Lake
Placid, NY]), anti-Flag (M2, Sigma), or anti-RORg (H-190, Santa Cruz Biotech-
nology). After washing, elution, and reversion of crosslinks, the DNA was iso-
lated and used in radioactive PCR reactions. The primers used for Actb and
CNS2a were as described before (Akimzhanov et al., 2007). The primers for
Il17 promoter were 50-GCAGCAGCTTCAGATATGTCC-30 and 50-GGGGTGA
CACCATTTGAGTAA-30.
Electrophoretic Mobility Shift Assays
Nuclear proteins from Th17 cells were prepared and used in electrophoretic
mobility shift assays (EMSAs) as described (Klein-Hessling et al., 1996). The
following oligonucleotides were used as probes and competitors and for the
introduction of mutations: ROR element (RORE) in Il17 CNS2 (CNS2), 50-GAAA
GTTTTCTGACCCACTTTAAATCAATTT-30; CNS2 RORE mutant (mutant), 50-G
AAAGTTTTCTGACACACTTTAAATCAATTT-30; and RORE consensus in Pcp2
promoter (consensus), 50- GGAGTCCCCTGACCCAGTTACTATAACACA-30.
Supplemental Data
Eight figures are available at http://www.immunity.com/cgi/content/full/28/1/
29/DC1/.
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